艾滋病病毒与丙型肝炎病毒混合感染的研究进展

刘志华 胡静

引用本文: 刘志华, 胡静. 艾滋病病毒与丙型肝炎病毒混合感染的研究进展[J]. 疾病监测, 2007, 22(8): 568-571. DOI: 10.3784/j.issn.1003-9961.2007.8.568 shu
Citation:  [J]. Disease Surveillance, 2007, 22(8): 568-571. DOI: 10.3784/j.issn.1003-9961.2007.8.568 shu

艾滋病病毒与丙型肝炎病毒混合感染的研究进展

English

    1. [1]Staples Jr CT,Rimland D,Dudas D.Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A.(Veterans Affairs Medical Center) Cohort Study (HAVACS):the effect of coinfection on survival[J].Clin Infect Dis,1999,29:150-154. [2]Sulkowski MS,Moore RD,Mehta SH,et al.Hepatitis C and progression of HIV disease[J].JAMA,2002,288:199-206. [3]Sherman KE,Rouster SD,Chung RT,et al.Hepatitis C virus prevalence among patients infected with human immunodeficiency virus:a cross-sectional analysis of the US adult AIDS Clinical Trials Group[J].Clin Infect Dis,2002,34:831-837. [4]Bica I,McGovern B,Dhar R,et al.Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection[J].Clin Infect Dis,2001,32:492-497. [5]Thomas DL,Shih JW,Alter HJ,et al.Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users[J].J Infect Dis,1996,174:690-695. [6]Greub G,Ledergerber B,Battegay M,et al.Clinical progression,survival,and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection:the Swiss HIV Cohort Study[J].Lancet,2000,356:1800-1805. [7]Koike K,Tsukada K,Yotsuyanagi K,Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan[J].Hepatol Res,2007,37(1):2-5. [8]Garten RJ,Zhang J,Lai S,et al.Coinfection with HIV and hepatitis C virus among injection drug users in southern China.Clin Infect Dis,2005,41(suppl):s18-s24. [9]Eyster ME,Alter HJ,Aledort LM,et al.J.Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)[J].Ann Intern Med,1991,115:764-768. [10]Bollepalli S,Mathieson K,Bay C,et al.Prevalence of Risk Factors for Hepatitis C Virus in HIV-Infected and HIV/Hepatitis C Virus-Coinfected Patients[J].Sex Transm Dis,2007,34(6):367-370. [11]Alter MJ,Margolis HS,Krawczynski K,et al.The natural history of community-acquired hepatitis C in the United States.The Sentinel Counties Chronic non-A,non-B Hepatitis Study Team[J].N Engl J Med,1992,327:1899-1905. [12]Mehta SH,Cox A,Hoover DR,et al.Protection against persistence of hepatitis C[J].Lancet,2002,359:1478-1483. [13]Thomas DL,Astemborski J,Rai RM,et al.The natural history of hepatitis C virus infection:host,viral,and environmental factors[J].JAMA,2000,284:450-456. [14]Villano SA,Vlahov D,Nelson KE,et al.Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection[J].Hepatology,1999,29:908-914. [15]Lesens 0,Deschenes M,Steben M,et al.Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus positive hemophiliacs and should be treated as an opportunistic infection[J].J Infect Dis,1999,179:1254-1258. [16]Soto B,Sanchez QuijanoA,RodrigoL,et al.Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis[J].J Hepatol,1997,26:1-5. [17]Benhamou Y,Bochet M,DiMartino V,et al.Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coin-fected patients.The Multivirc Group[J].Hepatology,1999,30:1054-1058. [18]Telfer P,Sabin C,Devereux H,Scott F,et al.The progression of HCV-associated liver disease in a cohort of haemophilic patients[J].Br J Haematol,1994,87:555-561. [19]Sanchez-Quijano A,Andreu J,Gavilan F,et al.Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C[J].Eur J Clin Microbiol Infect Dis,1995,14:949-953. [20]Graham CS,Baden LR,Yu E,et al.Influence of human immunodeficiency virus infection on the course of hepatitis C virus infections meta-analysis[J].Clin Infect Dis,2001,33:562-569. [21]Daar ES,Lynn H,Donfield S,et al.Relation between HIV-1 and hepatitis C viral load in patients with hemophilia[J].J Acquir Immune Defic Syndr,2001,26:466-472. [22]Laskus T,Radkowski M,Jablonska J,et al.Human immunodeficiency virus facilitates infection/replication of hepatitisC virus innative human macrophages[J].Blood,2004,103:3854-3859. [23]Vento S,Garofano T,Renzini C,et al.Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy[J].AIDS,1998,12:116-117. [24]Chung RT,Evans SR,Yang Y,et al.Immune recovery is associated with persistent rise in hepatitis C virus RNA,I nfrequent liver test flares,and is not impaired by hepatitis C virus in coinfected subjects[J].AIDS,2002,16:1915-1923. [25]Wit FW,Weverling GJ,Weel J,et al.Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combinationtherapy[J].J Infect Dis,2002,186:23-31. [26]Sulkowski MS,Moore RD,Mehta SH,et al.Hepatitis C and progression of HIV disease[J].JAMA,2002,288:199-206. [27]Rockstroh JK,Mocroft A,Soriano V,et al.Influence of hepatitis C virus infection on HIV -1 disease progression and response to highly active antiretroviral therapy[J].J Infect Dis,2005,192:992-1002. [28]Carrat F,Bani-Sadr F,Pol S,et al.Pegylated interferon alfa-2b vs standard interferon alfa-2b,plus ribavirin,for chronic hepatitis C in HIV-infected patients:a randomized controlled trial[J].JAMA,2004,292:2839-2848. [29]Torriani FJ,Rodriguez-Torres M,Rockstroh JK,et al.Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HFV-infected patients[J].N Engl J Med,2004,351:438-450. [30]Laguno M,Murillas J,Blanco JL.et al.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HrVTHCV co-infected patients[J].AIDS,2004,18:F27-F36. [31]Soriano V,Sulkowski M,Bergin C,et al.Care of patients with chronic hepatitis C and HIV co-infection:recommendations from the HIV-HCV International Panel[J].AIDS,2002,16:813-828. [32]Strader DB,Wright T,Thomas DL,et al.Diagnosis,management,and treatment of hepatitis C[J].Hepatology,2004,39:1147-1171. [33]Benson CA,Kaplan JE,Masur H,et al.Treating opportunistic infections among HIV-exposed and infected children:recommendations from CDC,the National Institutes of Health,and the Infectious Diseases Society of America[J].MMWR Recomm Rep,2004,53:1-112. [34]Qurishi N,Kreuzberg C,Luchters G et al.Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection[J].Lancet,2003,362:1708-1713. [35]Brau N,Salvatore M,Rios-Bedoya CF,et al.Slower fibrosis progression in HIV/HCV -coinfected patients with successful HIV suppression using antiretroviral therapy[J].J Hepatol,2006,44:47-55. [36]Marine-Barjoan E,Saint-Paul MC,Pradier C,et al.Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/ hepatitis C virus co -infected patients[J].AIDS,2004,18:2163-2170.

    1. [1]

      肖志明张秀丽刘生翔 . 676名女性性服务者HIV、TP、HBsAg和HCV感染状况调查分析. 疾病监测, 2006, 21(8): 445-446. DOI: 10.3784/j.issn.1003-9961.2006.8.445

    2. [2]

      刘云慧闫丽胡英刘小翠 . 北京市486名吸毒人员HIV、HCV和梅毒感染状况分析. 疾病监测, 2007, 22(1): 10-12. DOI: 10.3784/j.issn.1003-9961.2007.1.10

    3. [3]

      赵金仙陈良许杰鲁建波蔡英陈黎跃 . 云南省玉溪地区吸毒人群人类免疫缺陷病毒、丙型肝炎病毒、梅毒螺旋体感染状况及行为学调查. 疾病监测, 2008, 23(9): 558-559. DOI: 10.3784/j.issn.1003-9961.2008.9.558

    4. [4]

      张光彩马艳玲杨莉杨朝军崔文庆王玲阎文云王文新潘颂峰安静张小波罗红兵张勇贾曼红 . 云南省HIV与TP双重感染者的分析. 疾病监测, 2003, 18(4): 125-127. DOI: 10.3784/j.issn.1003-9961.2003.4.125

    5. [5]

      董宏伟蒋文雅陈胜林 . 舟山海岛地区卖淫妇女HIV感染情况调查分析. 疾病监测, 2003, 18(9): 331-333. DOI: 10.3784/j.issn.1003-9961.2003.9.331

    6. [6]

      古有婵吴宝燕周海李桂娇吴海东高赛珍 . 中山市吸毒人群艾滋病、梅毒感染情况及相关知识和行为调查. 疾病监测, 2005, 20(6): 301-304. DOI: 10.3784/j.issn.1003-9961.2005.6.301

    7. [7]

      崔允霞陈富传马秋莎 . 驻马店市2000-2002年HIV抗体初筛试验阳性调查分析. 疾病监测, 2004, 19(1): 10-13. DOI: 10.3784/j.issn.1003-9961.2004.1.10

    8. [8]

      葛增单多王璐高省丁国伟宋鲁平周建平何文生郭巍1彭志行 . 河南省驻马店市“艾滋病病毒单阳”家庭阴性配偶4种性病相关病毒感染调查. 疾病监测, 2009, 24(11): 846-848. DOI: 10.3784/j.issn.1003-9961.2009.11.012

    9. [9]

      王爱红 . 输血感染人类免疫缺陷病毒两例调查分析. 疾病监测, 2013, 28(3): 200-201. DOI: 10.3784/j.issn.1003-9961.2013.3.009

    10. [10]

      王拥军项蓉郭志宏杨雪梅 . 2003-2005年浙江省无偿献血者中艾滋病病毒感染检测分析. 疾病监测, 2007, 22(4): 238-239. DOI: 10.3784/j.issn.1003-9961.2007.4.238

    11. [11]

      徐兴洪兰景艺陈晓耕胡思丁刘洁叶英姿朱芝娟 . 浙江省景宁县“外来媳”人群艾滋病病毒感染状况及艾滋病相关知识调查. 疾病监测, 2008, 23(9): 571-572. DOI: 10.3784/j.issn.1003-9961.2008.9.571

    12. [12]

      王闻卿丁明苏靖华傅慧琴赵冰张勇琪黄红章红红朱林英朱渭萍傅益飞孙乔许学斌 . 上海市浦东新区腹泻病例中气单胞菌的流行和耐药特征研究. 疾病监测, 2016, 31(3): 225-228. DOI: 10.3784/j.issn.1003-9961.2016.03.011

    13. [13]

      张小清石林郁华王炳涛赵煜君 . 甘肃省2002年HIV国家哨点监测结果分析. 疾病监测, 2003, 18(12): 445-448. DOI: 10.3784/j.issn.1003-9961.2003.12.445

    14. [14]

      李小明 . 兰州市1999-2000年吸毒人员梅毒及艾滋病现状调查. 疾病监测, 2002, 17(3): 85-87. DOI: 10.3784/j.issn.1003-9961.2002.3.85

    15. [15]

      槐鹏程姜延峰杨霞王凯王赫秋赵丽马伟 . 辽宁省鞍山市艾滋病自愿咨询检测需求状况分析. 疾病监测, 2011, 26(6): 463-466. DOI: 10.3784/j.issn.1003-9961.2011.06.013

    16. [16]

      邹艳潘晓红杨介者马瞧勤 . 重点人群艾滋病自愿咨询检测需求分析. 疾病监测, 2007, 22(12): 814-817. DOI: 10.3784/j.issn.1003-9961.2007.12.814

    17. [17]

      郭卉吴尊友 . 在婚男男性接触者婚姻状况与性行为特征研究现状. 疾病监测, 2010, 25(8): 651-654. DOI: 10.3784/j.issn.1003-9961.2010.08.020

    18. [18]

      史宏博张继红洪航董红军 . 2001-2015年浙江省宁波市HIV/AIDS病例死亡特征分析. 疾病监测, 2016, 31(12): 1072-1075. DOI: 10.3784/j.issn.1003-9961.2016.12.021

    19. [19]

      陈海江张继红洪航王金贤姜海波 . 宁波市45家医院医护人员对性病就诊者开展HIV、梅毒检测的认知调查. 疾病监测, 2016, 31(12): 1041-1044. DOI: 10.3784/j.issn.1003-9961.2016.12.015

    20. [20]

      马宁阎涵周丹张岩王莉姚文清 . 辽宁省艾滋病病毒阳性男男性行为人群梅毒感染状况分析. 疾病监测, 2016, 31(8): 659-662. DOI: 10.3784/j.issn.1003-9961.2016.08.011

  • 加载中
计量
  • PDF下载量:  589
  • 文章访问数:  637
  • HTML全文浏览量:  11
  • 引证文献数: 0
文章相关
  • 收稿日期:  2007-05-21
  • 刊出日期:  2008-09-06
通信作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章

在线交流